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Abstract. 
 
Osteoprotegerin (OPG) and OPG-ligand 
(OPGL) potently inhibit and stimulate, respectively, os-
teoclast differentiation (Simonet, W.S., D.L. Lacey, C.R. 
Dunstan, M. Kelley, M.-S. Chang, R. Luethy, H.Q. 
Nguyen, S. Wooden, L. Bennett, T. Boone, et al. 1997. 
 
Cell.
 
 89:309–319; Lacey, D.L., E. Timms, H.-L. Tan,
M.J. Kelley, C.R. Dunstan, T. Burgess, R. Elliott,
A. Colombero, G. Elliott, S. Scully, et al. 1998. 
 
Cell.
 
 93:
165–176), but their effects on mature osteoclasts are not 
well understood. Using primary cultures of rat osteo-
clasts on bone slices, we ﬁnd that OPGL causes approx-
imately sevenfold increase in total bone surface ero-
sion. By scanning electron microscopy, OPGL-treated 
osteoclasts generate more clusters of lacunae on bone 
suggesting that multiple, spatially associated cycles of 
resorption have occurred. However, the size of individ-
ual resorption events are unchanged by OPGL treat-
ment. Mechanistically, OPGL binds speciﬁcally to ma-
ture OCs and rapidly (within 30 min) induces actin ring 
formation; a marked cytoskeletal rearrangement that 
necessarily precedes bone resorption. Furthermore, we 
show that antibodies raised against the OPGL receptor, 
RANK, also induce actin ring formation. OPGL-
 
treated mice exhibit increases in blood ionized Ca
 
11
 
 
within 1 h after injections, consistent with immediate 
OC activation in vivo. Finally, we ﬁnd that OPG blocks 
OPGL’s effects on both actin ring formation and bone 
resorption. Together, these ﬁndings indicate that, in ad-
dition to their effects on OC precursors, OPGL and 
OPG have profound and direct effects on mature OCs 
and indicate that the OC receptor, RANK, mediates 
OPGL’s effects.
Key words: osteoclast • bone resorption • bone re-
modeling • osteoporosis • hematopoietic cell growth 
factors
 
O
 
STEOCLASTS
 
 (OC)
 
1
 
 are bone resorbing cells of he-
matopoietic origin. They arise by the differentia-
tion of OC precursors of the monocyte/macro-
phage lineage and their function is required not only for
the development of the skeleton, but also for mineral ho-
meostasis and normal remodeling of bone in adult ani-
mals. The requirement for macrophage colony stimulating
factor/colony stimulating factor-1 (MCSF/CSF-1) in the
differentiation of OCs is well supported by in vivo and in
vitro evidence (Suda et al., 1992). CSF-1 alone, however, is
clearly not sufficient to cause differentiation of OCs from
hematopoietic progenitors. However, mature, functional
OCs will develop from spleen or bone marrow when co-
cultured with CSF-1-producing osteoblast-like stromal
cells in the combined presence of vitamin D3, and dexa-
methasone (Takahashi et al., 1988). Furthermore, both dif-
ferentiation and activation of OCs in this coculture system
have been shown to require physical contact between the
osteoblastic stromal cells and hematopoietic progenitors
(Rodan and Martin 1981; Udagawa et al., 1989; Fuller et al.,
1991; Suda et al., 1992; Jimi et al., 1996). Based on these
results, it has been proposed that a membrane-bound OC
factor on stromal cells would stimulate differentiation of
OC progenitors as well as activate mature OCs. Although
a number of approaches to elucidate the identity of the
proposed OC differentiation factor have been taken over
many years (Horton, 1972; Abe et al., 1986; Fuller et al.,
1991; Lee et al., 1991; Yoneda et al., 1993; Hentunen et al.,
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1. 
 
Abbreviations used in this paper:
 
 MCSF/CSF-1, macrophage colony
stimulating factor/colony stimulation factor-1; OC, osteoclasts; OPG/
OCIF, osteoprotegerin/osteoclast inhibitory factor; OPGL/ODF OPG,
ligand/osteoclast differentiation factor (identical to RANKL and
TRANCE); RANK, receptor activator of NF-
 
k
 
B; RANKL, RANK ligand
is identical to OPGL/ODF and TRANCE; TNF, tumor necrosis factor;
TNFR, TNF receptor; TRANCE, TNF-related activation-induced cyto-
kine is identical to OPGL/ODF; TRAF, TNFR-associated factor; TRAP,
tartrate resistant acid phosphatase. 
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1994), only very recently, and somewhat indirectly, has a
clear candidate for such a factor emerged.
Osteoprotegerin (OPG, also called osteoclast inhibition
factor, OCIF), a soluble member of the tumor necrosis
factor receptor family (TNFR), has profound inhibitory
effects on in vitro OC differentiation and bone resorption
in vivo (Simonet et al., 1997; Tsuda et al., 1997; Yasuda et
al., 1998a). The function of OPG was elucidated by over-
expression in transgenic mice, as well as by inhibition of
OC differentiation in vitro. OPG transgenic mice devel-
oped osteopetrosis with a severity correlated to the level
of transgene expression. Finally, OPG knockout mice
were recently shown to have severe osteoporosis (Bucay
et al., 1998). Taken together, these results provide strong
evidence that OPG regulation of OC differentiation is
necessary for the maintenance of normal bone density in
vivo.
Based on its homology to the TNFR family, Simonet et al.
(1997) proposed that OPG might act as a soluble decoy re-
ceptor to neutralize a putative OC stimulatory factor on
osteoblastic stromal cells, and thus prevent OC differen-
tiation. Direct expression cloning of a transmembrane
ligand for OPG (OPGL) has now been accomplished inde-
pendently by two groups (Lacey et al.,
 
 
 
1998; Yasuda et al.,
1998b). OPGL (also called osteoclast differentiation fac-
tor, ODF), identified using OPG-Fc fusion protein as a
probe, is a TNF-related transmembrane cytokine ex-
pressed by a number of different cell types, notably includ-
ing osteoblastic stromal cells (Lacey et al., 1998; Yasuda
et al., 1998b). OPGL completely replaces the require-
ments for stromal cells, vitamin D3 and glucocorticoids
during in vitro osteoclastogenesis from spleen or bone
marrow progenitors; it binds to a committed OC progeni-
tor and in the combined presence of CSF-l, stimulates the
rapid induction of a variety of characteristic OC genes in-
cluding c-src, tartrate resistant acid phosphatase (TRAP),
 
b
 
-3 integrin (a component of the 
 
a
 
v
 
b
 
3
 
 vitronectin recep-
tor), calcitonin receptor and cathepsin K (Lacey et al.,
1998; Yasuda et al., 1998b). Furthermore, administration
of OPGL to normal mice resulted in a dose-dependent
systemic hypercalcemia apparently due to increased OC
activity, but not an increase in the number of OCs on the
bone surface (Lacey et al., 1998). All of the potent effects
of OPGL in vitro and in vivo are completely inhibited by
OPG. These data provide evidence that OPGL and OPG
are key regulators of osteoclastogenesis.
OPGL is identical to RANKL (receptor activator of
NF-
 
k
 
B ligand) and TRANCE (TNF-related activation-
induced cytokine); and in vitro evidence suggests that it
may play a role in regulating interactions between T cells
and dendritic cells (Anderson et al., 1997; Wong et al.,
1997). The receptor for RANKL, RANK (receptor activa-
tor of NF-
 
k
 
B), was also shown to be involved in RANK
 
1
 
T cell survival in vitro (Anderson et al., 1997; Wong et al.,
1997). In addition, previous data suggested that RANK is
also the receptor for OPGL on differentiating (Lacey et
al., 1998 and Yasuda et al., 1998b) and mature OCs
(Fuller et al., 1998). Hsu et al. (1999) and Nakagawa et al.
(1998) have now provided strong evidence that osteoclas-
togenesis induced by OPGL (RANKL) is directly medi-
ated through RANK on OC precursor cells. Complete
support of a dual role for OPGL (RANKL) and RANK in
both immune functions and osteoclastogenesis was very
recently provided by Kong et al. (1999) who reported on
the OPGL knockout mouse. Mice lacking OPGL not only
have severe osteopetrosis and defective tooth eruption,
but also exhibit defects in T and B cell differentiation and
completely lack lymph nodes.
In addition to its role in OC differentiation, we previ-
ously reported that OPGL induces a dose-dependent in-
crease in the number of resorption lacunae generated by
mature OCs on cortical bone slices (Lacey et al., 1998),
suggesting that OPGL also directly activates mature OCs.
In the present study we investigate the mechanism by
which OPGL increases bone resorption, independent of its
role in OC differentiation, in cultures of mature rat OCs
and in mice. We present evidence that OPGL acts directly
on individual, mature OCs through RANK to rapidly stim-
ulate reorganization of the actin cytoskeleton and induces
multiple cycles of bone resorption.
 
Materials and Methods
 
OC Isolation, Characterization and Cell Culture
 
Quantitation of bone resorption by mature OCs was performed essen-
tially as described by Arnett and Dempster (1986; Lacey et al., 1998). In
brief, OCs isolated from the long bones of post-natal day 1–3 rat pups
were put into suspension by curretting the entire bone in culture media
(Hepes-buffered M199 pH 7.0 [GIBCO BRL] containing 10% FBS [Hy-
clone], penicillin, streptomycin, fungizone and glutamine [GIBCO BRL]).
Cells from at least two pups were pooled together for each experiment re-
ported. Large debris were removed by sedimentation at 1 
 
g
 
 for 1 min and
the supernatant was plated onto 4 mm
 
 3 
 
4 mm
 
 3 
 
400 
 
m
 
m bovine cortical
bone slices preequilibrated with HCO
 
3
 
-buffered (1.25 g/liter), M199 in 96-
well plates, or directly onto air dried FBS coated glass coverslips. The
mature OCs were allowed to attach for 30 min, then most of the more
abundant, but less-adherent bone marrow and bone cells were removed
by vigorous washing. This procedure generates a sparse culture of cells on
the bone slices or coverslips that is enriched for multinucleate, TRAP pos-
itive OCs (Fig. 1). Varying numbers of mononuclear cells are also present;
(Fig. 6), and although their identity was not established, some of them do
express 
 
a
 
v
 
b
 
3
 
 and form actin rings (see below) and are presumably imma-
ture, mononuclear OCs. The bone slices (
 
n
 
 
 
5 
 
4 for each condition) con-
taining mature rat OCs were placed into 24-well dishes with HCO
 
3
 
-buff-
ered M199 control media, or the same media containing test compounds
(as indicated) and were incubated for 24 h at 37
 
8
 
C in a humidified, 5%
CO
 
2
 
/95% air atmosphere. Coverslips containing OCs were incubated in
Hepes-buffered M199 (pH 6.8) in an air incubator at 37
 
8
 
C as indicated
below.
 
Bone Resorption Measurements
 
Following fixation with 0.25% glutaraldehyde, bone slices were stained
for TRAP (Sigma kit 387-A). Mature OCs were defined as highly TRAP
positive cells containing three or more nuclei (Fig. 1). The total number of
rat OCs on each bone slice was counted (typically 35–50; see Fig. 2 B) us-
ing bright field optics on a Nikon Eclipse 800 upright microscope and a
20
 
3
 
 objective. After counting, the OCs were removed using 50 mM
NH
 
4
 
OH and brief sonication. The resorption lacunae on the same bone
slices were then visualized by toluidine blue staining (Murrills and Demp-
ster, 1990). Individual resorption events were distinguished by a dark bor-
der of toluidine blue stain surrounding an excavation. The data presented
here record each resorption event separately; often several events are ap-
parent in what is classically called a resorption pit (see Fig. 3 A). The num-
ber of resorption events were counted (Lacey et al., 1998) and area mea-
surements were done via a calibrated MetaMorph image analyzer (Leica)
coupled to a Nikon Optiphot microscope. Starting at the bottom left hand
corner and working up, the entire surface area of each 4 mm
 
 3 
 
4 mm bone
slice was scanned for resorption lacunae until the entire surface area of
each bone slice was examined. When a resorption lacuna came into the
viewing screen, the scanning was stopped and the perimeter of each re- 
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sorption event was traced (see Fig. 3 A). The derived area of each individ-
ual measurement was transferred to a spreadsheet. The total number of
resorption events per bone slice, total area resorbed, and mean area per
event were calculated. The area measurements were sorted by treatment,
and the mean area and distribution of event sizes were examined through
an appropriate mixed model Analysis Of Variance (ANOVA) comple-
mented with Bonferroni’s test when the difference between means was
significant at alpha level equals 0.05. The corresponding
 
 P 
 
values are re-
ported in the text. In addition to means comparison, a variance heteroge-
neity test was performed on the data following the Brown-Forsythe’s test
(Cochran and Cox, 1957; Brown and Forsythe, 1974). This test was shown
to be robust to the underlying distribution. The corresponding
 
 P 
 
values
are reported in the text. All the analyses were performed using the Statis-
tical Analysis System software (SAS Institute Inc.) on the UNIX platform.
Two additional, independent experiments were performed and similarly
analyzed, the results of these are presented in the text.
 
Scanning Electron Microscopy
 
Mature rat OCs were isolated and plated on cortical bone slices as de-
scribed above. Following quantitative analysis of the toluidine blue
stained bone slices, they were sonicated in water to remove the stain and
any residue. They were dehydrated through a graded ethanol series and
left in 100% ethanol overnight. After air drying, the slices were placed in a
vacuum desiccator for several hours before being mounted on scanning
EM stubs. The mounted slices were sputter coated with 30 nm of gold/pal-
ladium. The specimens were examined on a JEOL 5022 scanning EM at
25 KV with a working distance of 20 mm. Resorption lacunae from each
slice were identified with scanning EM; representative examples were se-
lected for photography at 750
 
3
 
 magnification. For quantitative scoring of
the lacunae, the entire surface of two slices per condition, from two sepa-
rate experiments were analyzed (
 
n
 
 5 
 
4 slices/condition). A semi-quantita-
tive scale was used to indicate whether a resorbed area contained no ex-
posed collagen fibrils (Ø), a few collagen fibrils (
 
1
 
) or many collagen
fibrils (
 
11
 
). In addition, the resorbed areas were scored for whether they
contained, 1, 2, 3, or more resorption events within the resorbed area.
 
Antibodies
 
Mouse anti–rat 
 
b
 
3 was purchased from PharMingen, HRP-linked rabbit
anti-FITC was from DAKO, biotinylated goat anti–rabbit and biotin-
ylated horse anti–mouse were from Vector Labs. The rabbit polyclonal
anti-RANK antibodies used were generated against a recombinant
RANK extracellular domain (residues 31–211) fused to human IgG
 
g
 
1 Fc
(Hsu et al., 1999) essentially as previously described for OPG-Fc (Simonet
et al., 1997). The rabbit antiserum was affinity purified on a RANK (31-
211)-conjugated Sepharose column to generate the mono-specific anti-
RANK–specific antibodies used here.
 
Immunocytochemistry and OPGL Binding to
Isolated OCs
 
Mature rat OCs were isolated and plated on FBS coated glass coverslips
as described above. After a brief incubation in control media (
 
z
 
2 h) the
cells were fixed in cold acetone and air dried. The OCs were incubated for
2 h at room temperature with either FITC-labeled OPGL (Lacey et al.,
1998) at 20 
 
m
 
g/ml, rabbit anti-RANK at 2.8 
 
m
 
g/ml, or mouse anti–rat 
 
b
 
3 at
a 1:5 dilution. HRP-linked rabbit anti-FITC, biotinylated goat anti–rabbit
or biotinylated horse anti–mouse, respectively, were used to detect the
primary reagent. Avidin-Biotinylated enzyme Complex (Vector Labs)
was incubated with the biotinylated antibodies, and finally HRP activity
was detected using DAB. The coverslips were counterstained with hema-
toxylin. For competition experiments, a 10-fold excess of unlabeled
OPGL (200 
 
m
 
g/ml) was preincubated with FITC-OPGL, or anti-RANK
was preincubated with 28 
 
m
 
g/ml of the extracellular domain of RANK
both at 4
 
8
 
C overnight. All subsequent incubations were carried out ex-
actly as described above. In addition, an irrelevant mouse IgG incubation
served as a general negative control for the staining reagents.
 
Actin Ring Staining and Quantitation
 
Mature rat OCs isolated as above were plated onto FBS-coated coverslips
in Hepes-buffered M199 media (pH 6.8) containing 10% FBS. After re-
moval of the nonadherent cells, the coverslips were allowed to incubate
for 
 
z
 
1 h at 37
 
8
 
C before treatments were initiated. Media were replaced
with fresh control or test compounds in Hepes-buffered M199 media (pH
6.8) for the times indicated, then the coverslips were fixed, permeabilized,
and stained with a modified version of method 1 in Lakkakorpi and
Väänänen (1991). In brief, cells were fixed for 10 min in 3% paraformal-
dehyde, followed by 0.2% Triton X-100 permeabilization for 10 min. A
short blocking step in 5% normal goat serum was included before staining
for 1 h at room temperature with 5 units/ml Texas red–labeled phalloidin
(Molecular Probes). Coverslips were washed in PBS and then counter-
stained with DAPI before mounting onto slides using Prolong anti-fade
mounting medium (Molecular Probes). The OCs were identified on a Ni-
kon Eclipse 800 upright microscope equipped with epifluorescence optics.
OCs were defined as cells containing at least 3 nuclei, and every OC on
every coverslip was counted and scored for its type of actin cytoskeletal
structure (see Fig. 6 A) by a blinded investigator.
 
OPGL Treatment of Mice
 
Male BDF1 mice (
 
n
 
 5 
 
5) aged 6–8 wk were maintained on normal chow,
or were fed low calcium chow (0.02% vs. 0.6% in standard chow) for 48 h
before receiving varying doses of OPGL by intravenous injection in a PBS
carrier, or PBS alone as control. Orbital blood samples for ionized calcium
determination were obtained 1 h after injection from animals anesthetized
with inhaled isoflurane. Blood ionized calcium levels were then deter-
mined using a Chiron Diagnostics no. 634 blood ionized calcium/pH ana-
lyzer. Data (reported as mean 
 
6
 
 SEM) were evaluated by ANOVA with
Dunnett’s post hoc test to allow for multiple comparisons with control, us-
ing JMP statistical software (SAS Institute Inc.; Dunnett, 1955).
 
OPG, OPGL, and FITC-OPGL
 
The sources and preparation of the protein reagents used in this study
have been described in detail in Simonet et al., 1997 and Lacey et al., 1998.
In brief, recombinant murine OPGL [158-316] was expressed and purified
from 
 
E. coli
 
 (Lacey et al., 1998). FITC-coupled OPGL was prepared using
6-fluorescein-5-(and 6) carboxyamido hexanoic acid succinimidyl ester
(Molecular Probes) and murine OPGL [158-316] as described (Lacey
et al., 1998). A human OPG [22-201]-hu Fc fusion protein, expressed and
purified from Cho cells (Simonet et al., 1997), was used to inhibit the ac-
tion of OPGL in various experiments.
 
Results
 
OPGL Stimulates Mature OCs to Resorb Bone
 
We previously reported that treatment of mature OCs on
bone slices led to the generation of a dose-dependent in-
crease in the number of resorption lacunae (Fig. 7 in Lacey
et al., 1998). This increase in resorption events could arise
by a number of different mechanisms, for example, OPGL
might act directly on the OCs, or indirectly through action
on other cells in the culture. Whether direct or indirect,
OPGL may act as an OC survival factor, and thus increase
the total number of OCs in each experiment. Alterna-
tively, OPGL might activate quiescent OCs such that more
of the OCs in the culture are active, or OPGL may activate
individual OCs to undergo multiple cycles of resorption
during the assay period, or both. To investigate the mode
of OPGL action, mature OCs isolated from neonatal rat
long bones were plated onto cortical bone slices (Fig. 1) to
quantitatively and qualitatively assess the functional con-
sequences of OPGL on bone resorption.
The total area resorbed on each bone slice was quanti-
fied by image analysis (see Materials and Methods). We
found that OCs treated with OPGL resorb 
 
.
 
115,000 
 
m
 
m
 
2
 
(mean of
 
 n 
 
5 
 
4 bone slices) compared with untreated, con-
trol OCs which resorbed only 
 
z
 
16,000 
 
m
 
m
 
2
 
 of the bone
surface area (Fig. 2 A), representing about a sevenfold in-
crease in the total area resorbed per bone slice. This
marked increase in the total area resorbed was statistically 
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significant compared with each of the controls (
 
P
 
 
 
5
 
0.0001) and was completely inhibited by the addition of
OPG. However, by itself, OPG treatment of OCs did not
significantly alter the total area of bone resorbed com-
pared with the untreated control (
 
P
 
 
 
5 
 
0.59; Fig. 2 A). It is
noteworthy that both OPG-Fc alone and OPGL plus
OPG-Fc treated OCs retain a low level of basal resorption
activity. Furthermore, in contrast to the induction of OC
differentiation by OPGL (Lacey et al., 1998; Yasuda et al.,
1998b), the activation of mature OCs by OPGL occurs in
the absence of added CSF-1. In two independent replica-
tions of this experiment OPGL caused a similarly sig-
nificant stimulation of bone resorption. (Experiment 2
showed about a fourfold increase in the total area re-
sorbed/slice and was significant compared with each of the
controls,
 
 P 
 
5 
 
0.0001. Experiment 3 showed about a seven-
fold increase and this was significant compared with each
of the controls,
 
 P 
 
# 
 
0.0003).
 
OPGL Does Not Alter Mature OC Number
 
To address the possibility that OPGL was acting as a sur-
vival factor or inducing mononuclear OCs precursors to
fuse to form multinucleate OCs during the course of the
experiment, the total number of TRAP positive multinu-
cleate OCs were counted on each bone slice at the end of
the 24-h incubation period. We found that there was no
significant difference in the mean total number of OCs on
bone slices treated with control media, media containing
OPGL, OPG or the combination of OPGL and OPG, (
 
P
 
 
 
5
 
0.093; Fig. 2 B). These results show OPGL does not act by
increasing the number of multinucleate OCs in these ex-
periments. Two independent replications of this experi-
ment confirmed that OC numbers do not vary under these
different experimental conditions, however, the number of
OC per bone slice does vary between different experi-
ments. (Experiment 2, the mean OC number per slice
among the four different conditions were not significantly
different,
 
 P 
 
5 
 
0.17; experiment 3,
 
 P 
 
5 
 
0.20).
 
OPGL Increases the Area of Bone Resorbed per OC
 
To show that the overall effect of OPGL treatment on
OCs is to activate either more individual OCs, and/or to
activate some individual OC more, we have also expressed
the area data as the average of the resorbed area per
TRAP positive OC (Fig. 2 C). The data show the striking
and significant stimulation of OC resorption by OPGL
compared with each of the controls (
 
P
 
 
 
5 
 
0.0001). We find
that there is about an eightfold increase in the area re-
sorbed per OPGL-treated OCs compared with the control
OCs. In two independent replications of this experiment,
there was also an approximately eightfold increase in the
area resorbed per OPGL-treated OC compared with the
controls. (Experiment 2, the area resorbed per OPGL-
treated OC was significantly different from each of the
controls,
 
 P 
 
5 
 
0.0001; experiment 3,
 
 P 
 
5 
 
0.0001.)
 
OPGL Does Not Alter the Area of Individual 
Resorption Events
 
If OPGL induces mononuclear (pre)OCs in the cultures to
resorb bone, we would expect to observe an increase in the
number of very small resorption events compared with
control cultures. On the other hand, if OPGL induces fu-
Figure 1. Mature rat OCs
stain intensely for TRAP.
OCs isolated from the long
bones of 2-d-old rat pups
were plated on cortical bone
slices and stained for TRAP
(purple). Two representa-
tive examples are shown; on
average we obtain 30–50
OCs per 4 3 4 mm bone
slice, clearly the density of
OCs is low in these cultures.
Multinuclearity varies from
three to z30 nuclei per OC.
Mononuclear cells are visible
and some, but not all are
TRAP positive. Bar, 50 mm.
Figure 2. Treatment with
OPGL increases the total
area of bone resorbed with-
out altering OC number. (A)
The total area of bone re-
sorbed per bone slice (n 5 4)
was measured as described
in Materials and Methods.
Compared with control cul-
tures (untreated), OPGL at
10 ng/ml markedly stimulates
osteoclastic bone resorption.
A fivefold molar excess of
OPG-Fc (130 ng/ml) com-
pletely inhibited this stimula-
tion, while OPG-Fc alone
(130 ng/ml) has little effect on
bone resorption. Data are
shown 6 1 SD, compared
with the controls, OPGL sig-
nificantly stimulates the to-
tal area of bone resorbed per
bone slice (P 5 0.0001). (B)
OCs containing at least 3 nu-
clei and exhibiting strong
TRAP positive staining from
n 5 4 bone slices per condi-
tions were counted after 24 h
incubation with the indicated
treatments (as described
above). The data are pre-
sented as the average num-
ber of OCs per bone slice 6
1 SD, the differences were
not statistically significant (P 5 0.093). (C) The mean area of
bone resorbed per OC is presented for n 5 4 slices 6 SEM under
the same conditions as described above, the differences between
OPGL and controls were highly significant (P 5 0.0001). 
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sion of mononuclear cells, many larger resorption events
may be generated. To determine whether OPGL treat-
ment altered the area of individual resorption events, we
measured the area of each excavation generated by a sin-
gle round of resorption (Fig. 3 A illustrates on a scanning
EM how we define these individual resorption areas).
When the resorbed areas were closely related, we were
able to identify individual boundaries as darkly stained
borders separating individual events or as a prominent rim
in scanning EM (Fig. 3 A). As seen in Fig. 3 B, the mean
area per resorption event generated under the different
experimental conditions is not significantly different (
 
P
 
 
 
5
 
0.14). Furthermore, histograms of individual area mea-
surements suggested that the overall distribution of re-
sorption event sizes under the different conditions were
quite similar, with most being between 100 and 3,000 
 
m
 
m
 
2
 
(Fig. 3 C). Statistical analyses of the heterogeneity of vari-
ances (distribution of sizes) were performed using the
Brown-Forsythe’s test (Cochran and Cox, 1957; Brown
and Forsythe, 1974; see Materials and Methods). The re-
sults show that the variance of the event sizes among the
four groups was not different (
 
P 5 0.135) demonstrating
that there is no significant increase in the proportion of
small or large resorption events. Similar analysis on the
mean and variance of resorption event sizes from two ad-
ditional experiments yielded similar results. (Experiment
2, test of means P 5 0.24, test of variance P 5 0.37; experi-
ment 3, test of means P 5 0.58, test of variance P 5 0.92.)
OPGL Induces Individual Mature OCs to Undergo 
Multiple Cycles of Resorption
Scanning electron microscopy (scanning EM) was used to
assess if there were any qualitative changes in resorption
induced by OPGL. Bone slices were prepared for scanning
EM and representative examples of the resorption lacunae
observed are shown in Fig. 4. Resorbed areas generated
under control conditions, with OPGL and OPG together,
or OPG alone (Fig. 4, A, C, or D) were frequently single
or double events. In contrast, resorption areas generated
by OCs treated with OPGL (Figs. 3 A and 4 B) were fre-
quently connected with 3 to 7 individual resorption events
visible within one contiguous resorbed area (Fig. 3 A
shows four connected events, while Fig. 4 B shows three
connected resorption events). In addition, resorbed areas
generated in the presence of OPGL appeared to expose
more collagen fibrils regardless of the number of con-
nected events. The generation of physically connected re-
sorption events indicates that single OCs are being in-
duced by OPGL to undergo multiple resorption cycles
during the 24-h assay period.
To get a better idea about the magnitude of these quali-
Figure 3. OPGL does not
change the mean area nor the
distribution of sizes of indi-
vidual resorption events. (A)
A scanning EM showing a
typical resorption area gener-
ated by an OC treated with
OPGL (10 ng/ml) is shown in
the upper part of A. The
drawing in the lower part of
A illustrates how individual
resorption events are de-
fined by outlining the bound-
aries of an individual resorp-
tion cycle. These are seen as
the rim of individual excava-
tions by scanning EM here,
or as dark borders on tolui-
dine blue stained bone (not
shown). The areas of all of
the individual resorption
events on bone slices (n 5 4)
per condition were measured
as described in Materials and
Methods. The scale bar mea-
sures 25 mm. (B) The calcu-
lated mean area per resorp-
tion event 6 1 SD are shown: Control (untreated), OPG-Fc at 130 ng/ml, OPGL at 10 ng/ml, or a combination of OPGL and OPG-Fc at
the same concentrations. Differences between the mean areas per resorption event under the 4 conditions shown were not significant
(P 5 0.14). (C) The size distribution of resorption events are displayed in a normalized format to allow the distributions to be visually
compared. The number of resorption events differs depending on the different treatments and are shown in each individual panel. Note
that the number of resorption events generated by OCs treated with OPG-Fc appears atypically low because only n 5 3 slices were an-
alyzed, nonetheless, the ratio of resorption events to TRAP positive OCs on these bone slices were not statistically different from con-
trol. The results of the statistical analyses indicate that variances (distribution of event sizes) were not significantly different from the
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tative observations, we have analyzed the appearance of
all of the resorbed areas on four bone slices per condition
by scanning EM. To score for exposure of collagen fibrils,
we used a semi-quantitative scale where (Ø) equals no
fibrils exposed (e.g., Fig. 4, C and D), (1) equals a few
fibrils exposed (e.g., Fig. 4 A), and (11) equals numerous
exposed fibrils (e.g., Figs. 3 A and 4 B). We were able to
demonstrate a statistically significance difference (Ø vs.
1, 11) between exposure of collagen fibrils by OPGL
treated OCs (n  5 115 resorbed areas analyzed on four
bone slices from two separate experiments) and the un-
treated control group (n 5 31; P 5 0.0001) and the OPGL
vs. OPGL 1 OPG-Fc group, (n 5 30; P 5 0.005).
These same bone slices were also scored for the number
of resorption events within each resorbed areas by scan-
ning EM. Compared with each of the controls, OPGL
treated OCs generated a statistically significant skew to-
ward multiple-resorption events/resorbed area (the num-
ber of resorbed areas with 1 and 2 events were compared
with those with 3–7 events). (OPGL vs. control, P 5
0.0001; OPGL vs. OPG-Fc, P 5 0.0019; and OPGL vs.
OPGL  1 OPG-Fc, P 5 0.0044.)
Mature OCs Bind OPGL and Express the OPGL 
Receptor, RANK
To address whether OPGL acts directly on the mature
OCs we asked whether OPGL binds specifically to ma-
ture OCs, and if the recently described OPGL receptor,
RANK, (Nakagawa et al., 1998; Hsu et al., 1999), is ex-
pressed by OCs. A modified, but fully active form of
OPGL labeled with FITC (Lacey et al., 1998; see Materials
and Methods) was bound to fixed OCs on glass coverslips
(Fig. 5) or on bone (data not shown). To amplify the signal
from the bound OPGL-FITC, the OCs were incubated
with HRP-linked anti-FITC antibody. Essentially all of the
multinucleate cells were stained by OPGL-FITC as were
some, but not all, of the mononuclear cells (Fig. 5, A and
B). This staining was specifically competed by the addition
of excess unlabeled OPGL (Fig. 6 C). To determine if the
Figure 4. Scanning Electron Microscopy reveals that individual OCs are induced by OPGL to undergo multiple cycles of bone resorp-
tion. Bone slices from a typical experiment were prepared for, and viewed by scanning EM as described in Materials and Methods. The
figure reveals qualitative differences between resorption areas generated under the different conditions shown. (A) Control (un-
treated). (B) OPGL (10 ng/ml) treatment leads to the generation of numerous connected resorbed areas which expose a network of col-
lagen fibrils. (C) OPGL (10 ng/ml) and OPG-Fc (130 ng/ml) together. (D) OPG-Fc (130 ng/ml) alone. Bar, 25 mm.Burgess et al. OPGL Activates Mature Osteoclasts 533
OPGL receptor, RANK is expressed on the mature OCs
we used a polyclonal antibody directed against the extra-
cellular domain of the receptor (Hsu et al., 1999). Most of
the multinucleated OCs, as well as some of the mononu-
clear cells are positive for RANK (Fig. 5, D and E). To
demonstrate the specificity of this antibody, excess antigen
was preincubated with the antibody before incubation
with the OCs (Fig. 5 F). As a positive control, we stained
OCs with antibodies to the well characterized OC cell sur-
face protein, avb3 integrin (see Rodan and Rodan, 1997)
using a b3 integrin-specific antibody. Essentially all of the
large, multinucleate OCs stained with the b3 integrin anti-
body, as did some of the mononuclear cells (Fig. 5, G and
H). In contrast, cells stained with an isotype control anti-
body were all negative (Fig. 5 I). The staining with anti-
RANK is weaker than staining with either OPGL-FITC or
anti-b3, probably because the OPGL-FITC signal was am-
plified (see Materials and Methods), and b3 is expressed at
very high levels on OCs. From these combined data, it ap-
pears that OPGL binds directly to mature OCs by binding
the OPGL receptor, RANK which is clearly present on the
mature multinucleate OCs.
OPGL or Anti-RANK Induce the Rapid Reorganization 
of the OC Cytoskeleton into Actin Rings
To resorb bone, the OC must become polarized and form
a very tight seal with the substratum (bone) before pro-
tons and proteases are released into the specialized extra-
cellular resorption compartment. Numerous laboratories
have described the specialized actin ring structure that
overlies this zone of tight sealing (e.g., Turksen et al., 1988;
Figure 5. Mature osteoclasts specifically bind OPGL and express RANK. Osteoclasts plated on FBS-coated coverslips were stained as
described in Materials and Methods. (A) FITC-OPGL binding to multinucleate OCs. (B) Higher magnification of OPGL-binding to
multinucleate OCs, as well as some negative mononuclear cells from the same coverslip. (C) Competition of FITC-OPGL with unla-
beled OPGL completely blocks binding to OCs and mononuclear cells. (D) Anti-RANK binds to multinucleate OCs. (E) Higher mag-
nification of anti-RANK binding multinucleate OCs, as well as a few negative mononuclear cells from the same coverslip. (F) Competi-
tion with soluble RANK completely blocks anti-RANK binding to OCs and mononuclear cells. (G) Anti-b3 integrin reacts strongly with
multinucleate OCs. (H) Higher magnification of anti-b3 integrin stained OCs, as well as some negative mononuclear cells. (I) An irrele-
vant control mouse antibody does not stain any cells in the culture. A, C, D, F, G, and I are all at the same magnification, while B, E,
and H are at a higher magnification. Bars, 50 mm.The Journal of Cell Biology, Volume 145, 1999 534
Lakkakorpi et al., 1989, 1993; Nakamura et al., 1996; for
reviews see, Teti et al., 1991; Murrills et al., 1993; and
Väänänen and Horton 1995). (It is also called the clear
zone as the actin network in the actin ring appears to ex-
clude organelles from this region.) There is an excellent
correlation between actin ring formation and bone resorp-
tion (Lakkakorpi and Väänänen, 1991), and it appears
that actin ring formation is required for bone resorption
(Teti et al., 1991). Given our evidence suggesting that
OPGL directly activates mature OCs we were curious to
know if OPGL itself, or perhaps our polyclonal antibody
to its receptor RANK would stimulate the formation of
actin rings as a prerequisite to induction of the first round
of bone resorption during the assay.
To quantify actin ring formation in isolated OCs treated
under a variety of conditions, we stained fixed OCs for
F-actin with Texas red–labeled phalloidin and a blinded
investigator tallied the results. Several different types of
F-actin containing structures are seen in OCs under all of
the experimental conditions, and a few examples are
shown in Fig. 6 A. The dot-like structures have been called
podosomes, these appear to be short vertical bundles of
F-actin which coalesce into larger structures in a time-
dependent manner (Fig. 6 A, top panels; Teti et al., 1991;
Väänänen and Horton, 1991). The structures we identify as
partial-, full-, and multiple-actin rings are illustrated in the
bottom panels of Fig. 6 A. The tallied number of these lat-
ter structures present under the different conditions were
summed and the data are presented as a percentage of the
total number of multinucleate OCs (Fig. 6 B). About 25%
of OCs in control (untreated) cultures at time zero, 30 min
and 2 h contained actin rings. OPGL or anti-RANK anti-
body treatment for as little as 30 min increased the num-
ber of actin ring–containing OCs to z40–50% of the total.
Figure 6. OPGL and anti-RANK rapidly induce actin ring formation in mature OCs.
(A) Representative examples of F-actin–containing structures in mature OCs were
detected using Texas red–labeled phalloidin. OCs containing F-actin structures simi-
lar to those shown in the top row were not considered to be actin rings; while OCs
with partial, full, and multiple actin rings were scored as actin ring–containing OCs
(bottom row). The scale bar measures 50 mm. (B) The percentage of OCs containing
actin rings at time zero (open bar); 30 min (gray bars); or at 2 h (black bars) under
control (no treatment); OPGL (50 ng/ml for 30 min, 10 ng/ml for 2 h); anti-RANK (5
mg/ml); OPGL together with OPG-Fc (10 and 130 ng/ml, respectively); OPG-Fc (130
ng/ml); and anti-RANK together with soluble RANK (5 and 10 mg/ml), respectively,
are shown. The number of total OCs counted under the various conditions in this ex-
periment are shown above individual bars. Similar effects were seen in two other ex-
periments.Burgess et al. OPGL Activates Mature Osteoclasts 535
At 2 h, actin ring formation induced by exposure to
OPGL or anti-RANK antibodies increased further, reach-
ing z50–60%. To demonstrate the specificity of these ef-
fects, we used OPG to competitively inhibit OPGL or used
OPG alone. Compared with untreated controls, no in-
crease in the number of actin rings was observed under ei-
ther condition. Finally, when the extracellular domain of
RANK was preincubated with the anti-RANK before
treatment of the OCs, no stimulation of actin ring forma-
tion was observed. As an aside, the mono- and binuclear
cells were not included in the analysis shown, as they are
not classically defined as (multinucleate) OCs. We did find
that the binuclear cells had a similar response to OPGL
(2 h control: 29% of the binuclear cells had actin rings; 2 h
OPGL-treated: 59% of the binuclear cells had actin rings).
It was not possible to unambiguously distinguish mononu-
clear OCs from other mononuclear cells in the culture,
therefore, we could not determine with certainty if OPGL
stimulated actin cytoskeletal rearrangements in these cells.
Some mononuclear cells clearly contained podosomes and
actin ring structures while others contained prominent
stress fibers typical of fibroblasts, but these were present
in both the control and treated cultures. Taken together,
these results show that OPGL, signaling through its recep-
tor, RANK on multinucleate OCs, induces rearrangement
of the actin cytoskeleton into actin rings, a structure that is
required for OC polarization and the formation of a spe-
cialized extracellular bone resorption compartment, and
thus OC activity.
OPGL Stimulates a Rapid Onset of Hypercalcemia
in Mice
Because OPGL stimulation of isolated OCs induced rear-
rangement of the cytoskeleton within 30 min, and in-
creased bone resorption in vitro, we examined whether
OPGL could rapidly stimulate bone resorption by activat-
ing preexisting OCs in vivo. Randomized groups of mice
(n 5 5), were injected intravenously with OPGL at the
concentrations indicated (Fig. 7). After 1 h, the level of
ionized calcium in the blood was determined as a measure-
ment of OC activation, and the results are shown in Fig. 7.
OPGL dose-dependently increased whole blood ionized
calcium levels with significant increases seen at doses of
0.05, 0.1, and 0.5 mg/kg. Since we have previously shown
that 3 d treatment of mice with OPGL does not increase
the number of OCs at the bone surface these results sug-
gest that within the 1-h treatment time, enough preexisting
OCs have become activated by OPGL to produce a mea-
surable increase in ionized calcium in the blood. Mainte-
nance of mice on a low calcium diet for 48 h before dosing
with OPGL did not abrogate the significant increase in
blood levels of ionized calcium (data not shown), indicat-
ing that increases in gut calcium absorption are an unlikely
alternate explanation for the increased blood calcium
levels.
Discussion
In this report we investigated the role of the newly de-
scribed TNF-related protein, OPGL, in OC activation.
Previously, Lacey et al. (1998) and Yasuda et al. (1998b)
identified OPGL/ODF as the long sought OC differentia-
tion factor. Direct expression cloning was used indepen-
dently by the two groups to identify OPGL/ODF as the
ligand for OPG/OCIF. OPG is expressed only as a soluble
form and is now believed to act as a soluble decoy receptor
to regulate the action of OPGL on differentiation of OCs.
The data presented in the two reports provide strong evi-
dence that OPGL acts directly on a population of OC pro-
genitors, and together with CSF-1 induces terminal differ-
entiation into mature, active OCs. Our data also showed
that OPGL activated mature OCs to resorb bone in vitro
(Lacey et al., 1998), and recent work supports our previous
results (Fuller et al., 1998).
In this report we have shown that OPGL or agonist anti-
bodies to its receptor, RANK, act directly on fully differ-
entiated, mature OCs inducing individual OCs to undergo
a rapid rearrangement of their actin cytoskeleton into ac-
tin rings and to perform multiple cycles of bone resorption
as seen by scanning EM. The data demonstrate that many
individual OCs are induced to perform multiple cycles of
resorption during the assay period, but we also find that
more of the OCs in the cultures appear to be activated as
suggested by an increase in the number and density of
single, isolated resorption events generated by OPGL
treated OCs.
Because PTH has been shown to induce OPGL expres-
sion in primary osteoblasts (Yasuda et al., 1998b) and os-
teoblastic cell lines, (Fuller et al., 1998), it would be inter-
esting to more carefully quantify the relationship between
the size and spatial distribution of the resorption events as
reported by Murrills et al. (1990). They showed that PTH
treatment of rat OC cultures primarily increased the num-
ber of resorption foci (defined as resorption lacunae lying
within an area of bone covering 1/116th of a bone slice),
suggesting that more of the OCs were activated in PTH
treated cultures (presumably due to stimulation of OPGL
expression by osteoblastic cells present in the cultures).
Some of the multiple excavations we observe, especially
groups of smaller resorbed areas, may be generated by sin-
gle large OCs containing multiple actin rings (e.g., see Fig.
6 A, bottom right), or by small OCs performing multiple
resorption cycles in a focal region of the bone slice as the
result of OPGL activation.
Figure 7. OPGL rapidly in-
creases blood ionized cal-
cium levels in mice. Ran-
domized groups of mice
(n 5 5) were injected intra-
venously with various con-
centrations of OPGL or PBS
as a control as indicated.
At 1 h post-injection, blood
samples were obtained, ion-
ized calcium measurements
performed (see Materials
and Methods), and the data
are presented as the mean 6 SEM. At OPGL doses of 0.05, 0.1,
and 0.5 mg/kg, statistically significant increases in ionized calcium
were detected (* indicates significantly different compared with
PBS, P , 0.05, see Materials and Methods).The Journal of Cell Biology, Volume 145, 1999 536
In addition to the quantitative effects of OPGL on OCs,
we also found that the resorbed bone surfaces were quite
different: while resorbed areas generated by untreated
OCs are fairly smooth and usually single, areas resorbed
by OPGL activated OCs are frequently multiple con-
nected excavations, which expose numerous collagen fi-
brils. These continuous excavations appear to be very
similar to those described by Chambers et al. (1984)
resulting from OC resorption on anorganic bone (hydra-
zine treated) compared with the intermittent resorption
that occurred on whole bone. How these two observations
might be related is unknown, but may reflect different OC
residence times at the resorption site and/or the probabil-
ity that the OC will migrate to a new location under the
different conditions. It is possible that OC movement and
cycle reactivation is mediated by calcium released during
each resorption cycle (Malgaroli et al., 1989; Zaidi et al.,
1989; for review see Hall and Chambers, 1996).
We found that OPG inhibited the activation of isolated
OCs by OPGL in vitro, however basal OC activity was not
significantly decreased by OPG alone. However, OPG
caused an inhibitory trend in several independent experi-
ments. This might be due to the presence of endogenous
OPGL in the system, (either from the cell preparation, or
the serum) that excess OPG would inhibit. Dempster re-
ported similar observations at a recent meeting (Dempster
et al., 1998, The American Society for Bone and Mineral
Research. Abstract F087. Bone. 23:S432). Nonetheless,
even in the presence of excess OPG, OCs retain a low
level of basal resorbing activity suggesting that something
other than OPGL is responsible for regulating the basal
level of OC resorption. We cannot, however, rule out the
possibility that some residual ex vivo OC activity is due to
prior OPGL exposure of the OCs in vivo. The marked
stimulation of bone resorption in these cultures by OPGL
does not appear to be mediated by increases in the num-
ber of multinucleate OCs as their numbers did not signifi-
cantly change after the various treatments. In contrast,
Fuller et al. (1998) have recently reported that OPGL
(TRANCE) acts as an OC survival factor in vitro, as has
been well documented for CSF-1 (Fuller et al., 1993). This
apparent discrepancy may be explained by the fact that
our OC survival measurements were performed on OCs
cultured on bone slices, while those of Fuller et al., were
on OCs cultured on untreated glass coverslips (even in
their hands, OCs plated on bone do not require OPGL for
survival, see Fig. 2, Fuller et al., 1998). It seems likely that
under certain conditions, OPGL can act as a survival fac-
tor. Finally, in contrast to the action of OPGL on OC dif-
ferentiation, activation of mature OCs on bone, or stimu-
lation of actin ring formation on glass by OPGL occurs in
the absence of added CSF-1.
Initial observations that OPG treatment of growing
mice induced a very rapid (3 d) increase in bone density,
led us to consider that OPG might act to inhibit OC activ-
ity in addition to being an antagonist of OC differentiation
(Simonet et al., 1997). Furthermore, OPGL caused hyper-
calcemia within 2 d in vivo, possibly due to the activation
of preformed OCs (Lacey et al., 1998). By investigating
mature OCs in culture and performing very short-term in
vivo experiments, we have tried to distinguish between the
role of OPGL on OC differentiation and the action of
OPGL on stimulating mature OCs in culture, and preexist-
ing OCs in vivo to resorb bone: OPGL clearly plays a role
in both OC differentiation (Lacey et al., 1998; Yasuda et
al., 1998b) and OC activation in vitro (Lacey et al., 1998,
Fuller et al., 1998 and present data). The interpretation of
the 1 h in vivo treatment of mice with OPGL is complex,
as we cannot rule out the kidney as the source of the in-
crease in blood ionized calcium. However, we found that
mice maintained on a low calcium diet for 48 h still show a
significant and dose-dependent elevation in blood ionized
calcium in response to OPGL (see Materials and Methods;
data not shown), thus ruling out the gut absorption as the
source of calcium. Given the robust and rapid activation of
OCs in vitro by OPGL as evinced by both bone resorption
and actin ring formation shown here, it seems most likely
that OC activation is involved in vivo as well.
OPGL is identical to RANKL/TRANCE, (Wong et al.,
1997), and it has been previously suggested that RANK is
its receptor on OC progenitors (Lacey et al., 1998; Yasuda
et al., 1998b). Recently Hsu et al. (1999) and Nakagawa et al.
(1998) provided direct evidence that OPGL exerts its ac-
tivity on OC progenitors via its receptor RANK. We show
here that a monospecific antibody to RANK bound to iso-
lated multinucleate OCs demonstrating that RANK is
expressed at the surface by mature OCs. In support of
our result, Hsu et al. (1999) recently demonstrated that
RANK mRNA is expressed by mature OCs in situ. The
anti-RANK polyclonal antibody was found to activate
OCs as evinced by OC polarization and formation of actin
rings, in an apparently not independent manner to OPGL.
The most likely explanation is that the anti-RANK anti-
body was acting as an agonist by binding RANK, causing
receptor aggregation and signal transduction (see Naka-
gawa et al., 1998). Together these pieces of evidence impli-
cate RANK as the relevant receptor for OPGL mediated
cytoskeletal rearrangements and osteoclast activation.
At this time, it is unknown how liganding RANK leads
to cytoskeletal rearrangement and ultimately to activation
of bone resorption in the OC, however, several signaling
molecules have been specifically implicated in the cyto-
skeletal rearrangements associated with OC activation
that may also play a role in OPGL activation of OCs.
pp60c-src is clearly a central and key component involved in
activation of mature OCs. pp60c-src is highly expressed in
OCs (Horne et al.; Tanaka et al., 1992) and c-src2/2
knockout mice exhibit profound osteopetrosis (Soriano et
al., 1991) due to an inability of c-src2/2 OCs to become
polarized, form actin rings or ruffled borders; all of which
are necessary for bone resorption (Soriano et al., 1991;
Boyce et al., 1992; Lowe et al., 1993). More recent evi-
dence links the engagement of avb3 integrin via pp60c-src
(translocation and activation) to PI3 kinase activation
(Hall et al., 1995; Hruska et al., 1995; Nakamura et al.,
1995; Chellaiah and Hruska, 1996; Hruska et al., 1996;
Lakkakorpi et al., 1997; and Nakamura et al., 1997), and
association with the F-actin capping/severing protein,
gelsolin (Chellaiah et al., 1998). Thus for the first time, a
specific cytoskeletal protein (gelsolin) and mechanism
(reversal of actin capping to support further F-actin poly-
merization) have been implicated in OC activation by re-
ceptor engagement and cell attachment. The stimulation
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rangements beyond those induced by OC attachment and
integrin engagement, and leads to marked stimulation of
bone resorption. It will be very interesting to determine if
further enhancement of this signaling pathway involving
pp60c-src and PI3 kinase or a completely separate path is
responsible for OPGL-RANK–induced actin ring forma-
tion and OC activation. Recent data from several groups,
(Darnay et al., 1998; Wong et al., 1998; Hsu et al., 1999)
suggest that signaling through RANK is mediated by bind-
ing to TRAF (TNFR-associated factor) family members.
Data from Hsu et al. (1999) further suggests that JNK acti-
vation downstream of RANK/TRAF interactions may be
important for OC-like cell differentiation. Events down-
stream of OPGL-RANK–mediated OC cytoskeletal changes
remain to be investigated.
In summary, OPGL binds to individual mature OC-
inducing cytoskeletal changes indicative of OC activation
and stimulates multiple spatially associated cycles of ro-
bust bone resorption in vitro. These effects of OPGL are
very selective as they can be inhibited by the natural solu-
ble decoy receptor, OPG, or mimicked by agonistic anti-
bodies to the OPGL receptor, RANK. In addition, OPGL
given intravenously induces a rapid increase in blood ion-
ized calcium in mice suggesting that preexisting OCs are
activated by OPGL in vivo. Based on these many pieces of
evidence, we conclude that in addition to its role in OC
differentiation, OPGL is a potent and direct regulator of
OC activity in vitro and in vivo.
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